Physician profile
Nadia Din
NPI 1821232521
$7,564.63
in general payments reported to CMS, 2019-2025
20 companies · $2,487 in 2025
The $2,487 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,457 · 2020: $174 · 2021: $1,319 · 2022: $528 · 2023: $285 · 2024: $315 · 2025: $2,487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,919 · Travel and Lodging: $1,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,919.23 |
| Travel and Lodging | $1,166.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $3,785.62 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Smith+Nephew, INC. | $1,051.82 | 2021-2025 | Stravix, Grafix Pl, Renasys Go V2 Home |
| Stryker Corporation | $453.81 | 2019-2023 | Ortholoc 3di |
| Bioventus LLC | $279.88 | 2021-2022 | |
| Amgen INC. | $278.71 | 2024 | Krystexxa |
| Avinger INC. | $259.59 | 2021-2023 | Pantheris |
| Advanced Oxygen Therapy INC. | $258.68 | 2025 | Topical Oxygen Chamber For Extremities |
| Organogenesis INC. | $235.62 | 2019-2025 | Puraply Wound Matrix, Apligraf |
| Biocomposites INC | $194.15 | 2025 | Stimulan |
| Orthofix Medical, INC. | $152.67 | 2020 | |
| Wright Medical Technology, INC. | $144.35 | 2019 | |
| Liberty Surgical INC. | $125.28 | 2019 | |
| Biotissue Holdings INC. | $97.54 | 2022 | |
| Hydrofera LLC | $93.41 | 2021 | |
| Abbott Laboratories | $43.85 | 2025 | Jot Dx |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $41.94 | 2020-2022 | |
| Osiris Therapeutics INC. | $22.75 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $17.68 | 2022 | |
| Horizon Therapeutics Plc | $14.63 | 2023 | Krystexxa |
| Integra Lifesciences Corporation | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadia Din listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.